Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
12.2 USD | -2.52% | -0.74% | -48.07% |
May. 08 | Baird Adjusts Price Target on EyePoint Pharmaceuticals to $38 From $46, Keeps Outperform Rating | MT |
May. 08 | Earnings Flash (EYPT) EYEPOINT PHARMACEUTICALS Posts Q1 Revenue $11.7M | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-48.07% | 652M | |
+32.40% | 694B | |
+29.39% | 593B | |
-1.67% | 371B | |
+19.96% | 331B | |
+6.61% | 290B | |
+14.06% | 239B | |
-3.15% | 209B | |
+9.89% | 209B | |
+8.03% | 169B |
- Stock Market
- Equities
- EYPT Stock
- News EyePoint Pharmaceuticals, Inc.
- Transcript : EyePoint Pharmaceuticals, Inc. - Special Call